ArticleExpert opinion on orphan drugs2016

Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy.

Janelle M Spinazzola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.